Gangliosides in the Brain: Physiology, Pathophysiology and Therapeutic Applications

Keyphrases

• Gangliosides 100%
• Pathophysiology 100%
• Therapeutic Use 100%
• Brain Physiology 100%
• Parkinson's Disease 20%
• Disease Pathogenesis 20%
• Epilepsy 20%
• Huntington's Disease 20%
• Neurological Conditions 20%
• Cell Membrane 10%
• Relative Abundance 10%
• Alzheimer's Disease 10%
• Multiple Sclerosis 10%
• Sialic Acid 10%
• Clinical Trials 10%
• Biosynthetic Enzymes 10%
• Nervous System 10%
• Ion Channels 10%
• Cellular Dysfunction 10%
• GM1 Ganglioside 10%
• Acid Residue 10%
• Neurodegenerative Diseases 10%
• Gain-of-function mutation 10%
• Membrane Protein 10%
• Cell Signaling 10%
• Lipid Rafts 10%
• Childhood-onset 10%
• Membrane Microdomains 10%
• Amyotrophic Lateral Sclerosis 10%
• Disease Model 10%
• Beneficial Role 10%
• Glycosphingolipids 10%
• Potential Treatments 10%
• Very Early Onset 10%
• Healthy Aging 10%
• Disease Potential 10%
• Brain Health 10%
• Protein Channel 10%

Neuroscience

• Ganglioside 100%
• Parkinson's Disease 20%
• Huntington's Disease 20%
• Alzheimer's Disease 10%
• Multiple Sclerosis 10%
• Cell Membrane 10%
• Cell Signaling 10%
• Nervous System 10%
• Ion Channel 10%
• Ganglioside GM1 10%
• Sialic Acid 10%
• Neurodegenerative Disorder 10%
• Transmembrane Protein 10%
• Amyotrophic Lateral Sclerosis 10%
• Glycosphingolipid 10%
• Lipid Raft 10%
• Loss of Function Mutation 10%
• Membrane Microdomain 10%
• Experimental Epilepsy 10%

Biochemistry, Genetics and Molecular Biology

• Ganglioside 100%
• Enzyme 9%
• Sialic Acid 9%
• Cell Membrane 9%
• Signal Transduction 9%
• Clinical Trial 9%
• Transmembrane Protein 9%
• Loss of Function Mutation 9%
• Membrane Microdomain 9%
• Lipid Raft 9%
• Channel Protein 9%
• Glycosphingolipid 9%
• GM1 9%
• Healthy Aging 9%
• Experimental Epilepsy 9%